null
****** FREE SHIPPING on orders over $99. - Most orders ship the same day. ******

Carestart COVID-19 Antigen Rapid Diagnostic Test

UPC:
COVID-19 Antigen
MPN:
COVID-19 Antigen
CS PRICE $310.00
Frequently bought together:

Description

ACCESS BIO’S CARESTART™ COVID-19 Antigen

20 Tests per box

FDA Emergency Use Authorization Issued 10/8/2020

FOR PROFESSIONAL USE ONLY

This item is NOT returnable.

-Test involves a brief nasal swab taken by a trained healthcare professional.

-Test is simple to administer, receive, and review seamlessly.

-Offers result in as little as 10 minutes.

-Kit contains everything to perform test.

-No Machinery required to read result, as required by other rapid tests of like reliability, quality, and cost.

-Does not require an on site lab, any third party lab, or machines to use.

-Covered by Insurance CPT code 87426 accepted by Medicaid, Medicare, and most private insurances
for private point of care (POC) antigen detection.

-Test sensitivity is 99.6% on negative results and 88.4% on positive results.


RAPID POC TEST

Due to the highly contagious nature and global health crisis, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts
on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical.

As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.

  • Lateral flow assay
  • Rapid results in 10 minutes
  • Nasopharyngeal swab specimen collection
  • Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
  • Detect SARS-CoV-2 nucleocapsid protein antigen
  • Identify acute infection in symptomatic patients with 88.4% sensitivity and 100% specificity
  • Designated as a CLIA waived tests

TEST PRINCIPLES:

The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly
collected from symptomatic individuals who are suspected of COVID-19 by their healthcare providers.

 

PROCEDURE:

19a.jpg
 19b.jpg

 

RESULT INTERPRETATION:

 

19c.jpg

 

 

View AllClose